InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,471.63
(
0.20%
)
US TECH 100
19,206.52
(
0.22%
)
Dow Jones
39,171.09
(
0.13%
)
Brent Oil
86.23
(
1.32%
)
Bitcoin
63,122.87
(
0.84%
)
Post# of 203990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Larrywh

Send PM Follow Ignore
Followers 2
Posts 332
Boards Moderated 0
Alias Born 05/07/2008

Larrywh

Re: TheRaveninexile post# 197106

Friday, 07/17/2009 2:15:25 PM

Friday, July 17, 2009 2:15:25 PM

Post# of 203990
True...

It would be a battle between the health insurance companies (that are equally as profit-oriented) and the hospital-pharmas. IMO Phase III approval of Nicosan would likely catapult it to become the #1 drug of choice. With so much publicity gathering steam on keeping the cost of health care down, this Infant Drug should accomplish its full potential in due time. Once the milestone is crossed, the world-wide use of Nicosan will become a standard protocol of treatment for SCD.

By the way, the dot-triple-zero XeChem would be remembered fondly as a very very inexpensive stock!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up